Liquid Biopsy Market
The liquid biopsy market consists of advanced, noninvasive diagnostic tests that analyze biological markers from fluid samples like blood. Primary customers include hospitals, laboratories, specialty clinics, and research centers. Key growth drivers are the rising incidence of cancer, the growing demand for less invasive diagnostic procedures, and the increasing adoption of personalized medicine.
CAGR
11.9%
Compound Annual Growth Rate
Current Value
$14.9B
Estimated 2026
Projected Value
$36.6B
By 2034
Get full access to
this market report
Sign up to unlock detailed analysis, startup opportunities, and competitive insights for "Liquid Biopsy Market".
Opportunity & Timing Scores
Barrier Analysis (Capital, Technical, Regulatory)
Key Players & Competitive Landscape
Curated Startup Ideas
7-day free trial
Cancel anytime
Secure payment